Similar articles for PMID: 16158924

Year	Number of Results
1994	2
1995	1
1996	2
1997	4
1998	3
1999	3
2000	3
2001	3
2002	4
2003	8
2004	16
2005	25
2006	11
2007	16
2008	13
2009	12
2010	7
2011	9
2012	7
2013	4
2014	1
2015	6
2016	3
2017	2
2018	2
2019	3
2021	2
2022	1
2024	0

1

Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.

Merseburger AS, Hennenlotter J, Simon P, Kruck S, Koch E, Horstmann M, Kuehs U, Küfer R, Stenzl A, Kuczyk MA. Merseburger AS, et al. Anticancer Res. 2005 May-Jun;25(3B):1901-7. Anticancer Res. 2005. PMID: 16158924 Free article.

2

Prognostic significance of Id-1 and its association with EGFR in renal cell cancer.

Li X, Zhang Z, Xin D, Chua CW, Wong YC, Leung SC, Na Y, Wang X. Li X, et al. Histopathology. 2007 Mar;50(4):484-90. doi: 10.1111/j.1365-2559.2007.02637.x. Histopathology. 2007. PMID: 17448024

3

Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.

Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R, Rimm D, Burtness BA. Psyrri A, et al. Clin Cancer Res. 2005 Aug 15;11(16):5856-62. doi: 10.1158/1078-0432.CCR-05-0420. Clin Cancer Res. 2005. PMID: 16115926

4

Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression.

Kruck S, Bedke J, Hennenlotter J, Ohneseit PA, Kuehs U, Senger E, Sievert KD, Stenzl A. Kruck S, et al. Oncol Rep. 2010 Jan;23(1):159-63. Oncol Rep. 2010. PMID: 19956876

5

Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.

Lee CM, Lee RJ, Hammond E, Tsodikov A, Dodson M, Zempolich K, Gaffney DK. Lee CM, et al. Gynecol Oncol. 2004 Apr;93(1):209-14. doi: 10.1016/j.ygyno.2004.01.006. Gynecol Oncol. 2004. PMID: 15047238

6

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS. Klatte T, et al. Clin Cancer Res. 2007 Dec 15;13(24):7388-93. doi: 10.1158/1078-0432.CCR-07-0411. Clin Cancer Res. 2007. PMID: 18094421

7

The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.

Cohen D, Lane B, Jin T, Magi-Galluzzi C, Finke J, Rini BI, Bukowski RM, Zhou M. Cohen D, et al. Clin Genitourin Cancer. 2007 Mar;5(4):264-70. doi: 10.3816/CGC.2007.n.002. Clin Genitourin Cancer. 2007. PMID: 17553206

8

Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.

Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C. Zigeuner R, et al. Urology. 2004 Apr;63(4):651-5. doi: 10.1016/j.urology.2003.11.011. Urology. 2004. PMID: 15072872

9

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L. Ang KK, et al. Cancer Res. 2002 Dec 15;62(24):7350-6. Cancer Res. 2002. PMID: 12499279 Clinical Trial.

10

Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.

Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO. Kramer C, et al. Cancer. 2007 May 15;109(10):2016-24. doi: 10.1002/cncr.22627. Cancer. 2007. PMID: 17394193 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

164 results

Results by year